These cancers include CNS tumors such as optic glioma and astrocytoma resulting from NF1 mutations, and osteosarcoma, soft-tissue sarcoma and ACT resulting from TP53 mutations. The gene discussed is NF1; the disease is soft tissue sarcoma.